期刊文献+

淋巴系统增殖性疾病患者EB病毒感染的检测结果分析

Analysis of the Detection for the LPD Patients with EB Infection
下载PDF
导出
摘要 目的:分析淋巴系统增殖性疾病(lymphoproliferative disease,LPD)患者EB病毒(Epstein-Barr virus,EBV)感染的检测结果。方法:回顾性分析70例LPD患者与70例健康志愿者血清EBV特异性抗体、血清细胞因子以及单个核细胞中EBV DNA拷贝数检测结果。结果:两组入选者血清VCA-Ig G和VCA-Ig M阳性率比较,无明显差异(P>0.05);PLD组患者血清EA-Ig G阳性率显著高于正常对照者(P<0.05);两组入选者血清IL-18、IFN-γ水平无明显差异(P>0.05);PLD患者EBV DNA拷贝数显著高于正常对照者(P<0.05)。结论:LPD患者存在EBV的激活感染,是导致LPD患者淋巴系统功能异常的主要原因,EBV的激活感染可能参与LPD的发病过程。 Objective: To analyze the detection results for the patients with lymphoproliferative disease (LPD) accompanied with the infection of EB. Methods: The EBV specific antibody, serum cytokine, EBV DNA copy number in peripheral blood mononuclear cells ( PBMNC ) of 70 LPD patients and 70 healthy volunteers were analyzed and compared. Results: The positive rates of VCA-IgG and VCA-IgM were not significantly different in two groups (P 〉 0. 05) ; The positive rate of EA-IgG in the PLD patient group was higher than that in the control group(P 〈0.05) ; the levels of IL-18 and IFN-γ were not significantly different between the 2 group (P 〉0.05) ; the EBV DNA copy number in PBMNC of the PLD patient group was higher than that in the control group ( P 〈 0.05 ). Conclusion: The patients with LPD show the active infection of EBV, that is the main reason for the abnormal function of lymphatic system in the patients with LPD. The active infection of EBV maybe involve in PLD pathogenesis.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第3期702-705,共4页 Journal of Experimental Hematology
关键词 淋巴系统增殖性疾病 EB病毒 EB病毒检测 lymphoproliferative disease EBV EBV test
  • 相关文献

参考文献12

二级参考文献182

  • 1靳淑玲,王北宁.系统性红斑狼疮与细胞因子的临床探讨[J].免疫学杂志,2000,16(z1):106-107. 被引量:4
  • 2李景廉,凌启南,黄启洪,许奕伟,简少文,罗慧玲,李满技.511例鼻咽癌高危人群监测7年中IgA/VCA滴度的变化[J].肿瘤防治研究,1995,22(6):344-346. 被引量:2
  • 3邓继岿,郑跃杰,袁雄伟,白大明.儿童非典型EB病毒感染的临床回顾分析[J].中国实用儿科杂志,2006,21(2):123-125. 被引量:35
  • 4卢愿,孙立荣,庞秀英,吕振华,隋爱华,李学荣,宋爱琴.EB病毒在儿童白血病患者中的感染状况及其临床意义——附35例报告[J].癌症,2007,26(1):54-57. 被引量:3
  • 5Iwakiri D, Takada K. Role of EBERs in the pathogenesis of EBV infection. Adv Cancer Res, 2010; 107 : 119 - 136.
  • 6Samanta M, Takada K. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis. Cancer Sci, 2010;101(!) :29 -35.
  • 7Harabuchi Y, Takahara M, Kishibe K, et al. Nasal natural killer (NK)/T-ceU lymphoma: clinical, histological, virological, and genetic features. Int J Clin Oncol, 2009;14(3) :181 - 190.
  • 8Samanta M, Iwakifi D, Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene, 2008 ;27 (30) :4150 - 4160.
  • 9Davis JM 3rd, Knutson KL, Strausbauch M_A, et al. Analysis of complex biornarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol, 2010;184(12) :7297 -7304.
  • 10Irons RD, Le AT. Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV infected human B lymphocytes. Chem Biol Interact,2008 ;172 ( 1 ) : 81 -92.

共引文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部